News

Name: Valo
Price range: $

Investors

Canaccord Genuity's 43rd Annual Growth Conference

August 9, 2023 • Valo Health

Yale Innovation Summit

June 1, 2023 • Valo Health

Jefferies Global Healthcare Conference

June 7, 2023 • Valo Health

View all

Publications

C-type natriuretic peptide induces inotropic and lusitropic effects in human 3D-engineered cardiac tissue: Implications for the regulation of cardiac function in humans

July 26, 2023 • Valo Health

Acute effects of cardiac contractility modulation stimulation in conventional 2D and 3D human induced pluripotent stem cell-derived cardiomyocyte models

November 10, 2022 • Valo Health

Activin A directly impairs human cardiomyocyte contractile function indicating a potential role in heart failure development

November 10, 2022 • Valo Health

View all Publications

In the News

Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica

View all News

Press Releases

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence

Valo Health to Participate in the Jefferies Global Healthcare Conference

View all Press Releases